Skip to content
Biodatica
Start free

ToLymph Inc.

Rochester, Minnesota

OncologyPhase II
Compare Sign in to watch

What changed

Study registered, no phase assigned: Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)

2mo agoTrial registeredMay 4, 2026Source filing (opens the source filing in a new tab)

Momentum

95no change

Momentum 95 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

1,171 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE2 registered

    Nov 18, 2024

    Carcinoma, Non-Small-Cell Lung Cancer (NSCLC) · RECRUITING · sponsor: ToLymph Inc. · An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer

    ClinicalTrials.gov · NCT06693336 (opens the source filing in a new tab)

  2. Trial

    NA registered

    Mar 6, 2024

    Lung Cancer (Diagnosis) · ACTIVE_NOT_RECRUITING · sponsor: University Health Network, Toronto · Margin Intraoperative CT Feedback Feedback Study

    ClinicalTrials.gov · NCT07242053 (opens the source filing in a new tab)

  3. Trial

    NA registered

    Aug 18, 2023

    Suspected Sarcoidosis · RECRUITING · sponsor: University Health Network, Toronto · Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis

    ClinicalTrials.gov · NCT06220526 (opens the source filing in a new tab)

  4. Trial

    NA registered

    Feb 1, 2013

    Lung Cancer · RECRUITING · sponsor: University Health Network, Toronto · Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)

    ClinicalTrials.gov · NCT01786590 (opens the source filing in a new tab)

  5. Trial

    Study registered

    Oct 1, 2011

    Lung Cancer · RECRUITING · sponsor: University Health Network, Toronto · Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer

    ClinicalTrials.gov · NCT01487603 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources